We have long-standing collaborations with the following NIHR Biomedical Research Centres (BRCs):

• Leicester
• Birmingham
• University College London Hospitals (UCLH)
• Newcastle

Through our work on the STOP HCV study we collaborate with 7 different NIHR BRCs in Oxford, Cambridge, Newcastle, Bristol, Kings College London, UCLH and Imperial. In addition, our GI Epidemiology Group has worked with the Clinical Practice Research Datalink for a number of high profile publications.

The Nottingham Molecular Pathology Node (NMPN) (£2.4M:EPSRC/MRC) is a joint venture with Respiratory; we are currently harnessing its computational and molecular pathology pipelines to transform multiplatform biomarker testing into clinical decision making tools.